Vivos Therapeutics Inc
NASDAQ:VVOS
Vivos Therapeutics Inc
PP&E Gross
Vivos Therapeutics Inc
PP&E Gross Peer Comparison
Competitive PP&E Gross Analysis
Latest Figures & CAGR of Competitors
Company | PP&E Gross | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Vivos Therapeutics Inc
NASDAQ:VVOS
|
PP&E Gross
$4.7m
|
CAGR 3-Years
75%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
DaVita Inc
NYSE:DVA
|
PP&E Gross
$5.5B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
10%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
PP&E Gross
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
CVS Health Corp
NYSE:CVS
|
PP&E Gross
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Cigna Corp
NYSE:CI
|
PP&E Gross
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
PP&E Gross
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Vivos Therapeutics Inc's PP&E Gross?
PP&E Gross
4.7m
USD
Based on the financial report for Dec 31, 2023, Vivos Therapeutics Inc's PP&E Gross amounts to 4.7m USD.
What is Vivos Therapeutics Inc's PP&E Gross growth rate?
PP&E Gross CAGR 5Y
30%
Over the last year, the PP&E Gross growth was -2%. The average annual PP&E Gross growth rates for Vivos Therapeutics Inc have been 75% over the past three years , 30% over the past five years .